ProShare Advisors’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-3,406
| Closed | -$1.08M | – | 2030 |
|
|
2023
Q4 | $1.08M | Buy |
3,406
+943
| +38% | +$298K | ﹤0.01% | 744 |
|
|
2023
Q3 | $416K | Buy |
2,463
+41
| +2% | +$6.93K | ﹤0.01% | 1009 |
|
|
2023
Q2 | $525K | Sell |
2,422
-3,791
| -61% | -$822K | ﹤0.01% | 926 |
|
|
2023
Q1 | $1.13M | Sell |
6,213
-519
| -8% | -$94.3K | ﹤0.01% | 708 |
|
|
2022
Q4 | $1.32M | Buy |
6,732
+582
| +9% | +$114K | ﹤0.01% | 682 |
|
|
2022
Q3 | $1.38M | Buy |
6,150
+871
| +16% | +$196K | 0.01% | 676 |
|
|
2022
Q2 | $667K | Sell |
5,279
-1,969
| -27% | -$249K | ﹤0.01% | 851 |
|
|
2022
Q1 | $918K | Sell |
7,248
-1,769
| -20% | -$224K | ﹤0.01% | 957 |
|
|
2021
Q4 | $1.18M | Sell |
9,017
-142
| -2% | -$18.6K | ﹤0.01% | 946 |
|
|
2021
Q3 | $1.12M | Sell |
9,159
-1,894
| -17% | -$232K | ﹤0.01% | 864 |
|
|
2021
Q2 | $1.26M | Buy |
11,053
+3,093
| +39% | +$353K | ﹤0.01% | 905 |
|
|
2021
Q1 | $957K | Buy |
7,960
+324
| +4% | +$39K | ﹤0.01% | 1016 |
|
|
2020
Q4 | $776K | Buy |
7,636
+1,413
| +23% | +$144K | ﹤0.01% | 1002 |
|
|
2020
Q3 | $481K | Sell |
6,223
-59
| -0.9% | -$4.56K | ﹤0.01% | 956 |
|
|
2020
Q2 | $700K | Buy |
6,282
+2,083
| +50% | +$232K | ﹤0.01% | 813 |
|
|
2020
Q1 | $302K | Sell |
4,199
-2,048
| -33% | -$147K | ﹤0.01% | 870 |
|
|
2019
Q4 | $471K | Buy |
+6,247
| New | +$471K | ﹤0.01% | 1095 |
|